Genetisch bedingte Candidose 1 ist eine autosomal dominante Erkrankung, die durch genetische Veränderungen im Bereich von 2p22.3-p21 ausgelöst wird, und mit einer Schilddrüsenerkrankung einhergehen kann.
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
| 1. |
Sams WM et al. (1979) Chronic mucocutaneous candidiasis. Immunologic studies of three generations of a single family.
|
| 2. |
Canales L et al. (1969) Immunological observations in chronic mucocutaneous candidiasis.
|
| 3. |
Wells RS et al. (1972) Familial chronic muco-cutaneous candidiasis.
|
| 4. |
Montes LF et al. (1971) Prolonged oral treatment of chronic mucocutaneous candidiasis with Amphotericin B.
|
| 5. |
Jorizzo JL et al. (1980) Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model.
|
| 6. |
Zimmermann-Belsing T et al. (1994) Riedel's thyroiditis: an autoimmune or primary fibrotic disease?
|
| 7. |
Loeys BL et al. (1999) Fungal intracranial aneurysm in a child with familial chronic mucocutaneous candidiasis.
|
| 8. |
Atkinson TP et al. (2001) An immune defect causing dominant chronic mucocutaneous candidiasis and thyroid disease maps to chromosome 2p in a single family.
|
| 9. |
Zuccarello D et al. (2002) Familial chronic nail candidiasis with ICAM-1 deficiency: a new form of chronic mucocutaneous candidiasis.
|
| 10. |
Ee HL et al. (2005) Autosomal dominant familial chronic mucocutaneous candidiasis associated with acne rosacea.
|